Zaaphire Biotech

Zaaphire Biotech is a biotech company with headquarters in Canberra, Australia. It manufactures the drug Riezene, which is used by mechanically augmented people to prevent Darrow Deficiency Syndrome and is used as a cheaper alternative to Neuropozyne.

Although Zaaphire publicly positions itself as a competitor to Neuropozyne manufacturer VersaLife, Zaaphire is in fact a proxy firm under the control of VersaLife owner Bob Page.